Welcome to the second meeting of the international Histoplasmosis advocacy Group (iHAG), is co-organized by the Fundação de Amparo a Pesquisa do Estado do Amazonas (FAPEAM), the Pan American Health Organization (PAHO) and the Center for Disease Control and Prevention (CDC). With co-sponsorship of the Global Action Fund for Fungal Infections (GAFFI), the International Society for Human and Animal Mycology (ISHAM) and the Mycoses Study Group Education and Research Consortium (MSGERC).

​

The inaugural meeting in 2015 brought together colleagues from 13 different countries to discuss how to better diagnose and treat histoplasmosis.  The meeting concluded with the goal of 80 by 20, striving by the year 2020 to have 80% of countries in the Americas to possess the capacity to rapidly diagnose and treat the disease.

 

The second meeting will focus on the status of capacity to diagnose and treat Histoplasmosis throughout the regions, as well as new developments in both laboratory and treatment options.  The agenda will be composed of keynote lectures, scientific talks, country updates, and policy discussions. 

 

We hope that many scientist, doctors and health representatives from the different countries will join iHAG this year in Manaus.